IAARHIES (The International Academic Association of Researchers in Humanities, IT, Engineering & Science)

IAARHIES International Conference on Lung Cancer & Drug Development ICLCDD - 2023, Webinar ICLCDD - 2024 26 March, 2024

IAARHIES International Conference on Lung Cancer & Drug Development ICLCDD - 2023 webinar-iclcdd-2024, 26 March, 2024

(Call for Papers/Posters)

Conference Details:

Important dates to remember: 

Conference dates:

26 March, 2024

Call for papers deadline:

25 March, 2024

Special Registration in Advance:

30 January, 2024

Last date to submit final abstract/full paper:

25 March, 2024

Submission of Proposal

Please click here to submit

Contact E-mail:

info@iaarhies.org

Venue:

Online via Zoom

General Conference Information:

IAARHIES - The Society for Academic Research (Regd.) is pleased to announce its CALL FOR PAPERS for International webinar on Lung Cancer & Drug Development - ICLCDD - 2024 being organized at its online portal. 

Academicians and researchers are invited to submit full-length papers, research-in-progress papers, case studies, doctoral dissertation, or abstracts to IAARHIES International webinar on Lung Cancer & Drug Development - ICLCDD - 2024 which will be held online at zoom on 26 March, 2024. The call for Papers and Posters will be open till 25 March, 2024.

The conference will distill the latest data on targeted agents, immunotherapy, surgery, and radiation oncology for the management of lung cancer. We will also preview novel agents and strategies with the potential to shape the future of lung cancer therapy. Cutting-edge lectures, extended panel discussions, multidisciplinary tumor boards, and question-and-answer sessions will allow participants to engage with international and national experts as they share their perspectives and personal experiences of clinical challenges and ongoing controversies in lung cancer management.

The ICLCDD – 2024 aims to bring together information system researchers, scientists, Academicians and research scholars to exchange and share their experiences, new ideas and research results about all aspects and subjects under lung cancer and discuss the practical challenges encountered and the solutions adopted. The research results are accepted in form of full-length papers, short papers, research-in-progress papers, case studies, doctoral dissertation and thesis encompassing statistical, factual, empirical, or experimental data. 

The delegates can feel free to share the particular subject oriented aspects varying from the major and critical challenges faced in any of the above areas worldwide along with the possible solutions and recommendations available as on date to combat these challenges.

The conference is affiliated with indexed journals published by IAARHIES – The Society for Academic Research (regd.) and conference participants are provided with the opportunity to submit the papers for online (open access) publication in these journals. (Journal of Innovative Research in Clinical & Medical Sciences issued by The Society for Academic Research ISSN No: 2456-7736)

Please note that all the associated subject based IAARHIES international journals follow double-blind peer-review process system. The decision on publication will depend on the peer-review process of the full manuscript by the concerned journal’s editorial team.

Mode of Participation

    Mode of Participation: The participation in the event is available under the following categories: 

    • Oral Presentation,
    • Poster Presentation,
    • Virtual Presentation
    • Listener 

Questions?

For questions on the submission and registration process, please feel free to e-mail us at: frontdesk@iaarhies.org.

Venue of the Event & Tentative Schedule:

Online at zoom

 

Registration

Registration charges: The webinar is free to join online. 

Sponsorship: Sun Pharma Oncology 

 

 


Submit the Abstract Online Register Now Join As a listener
Conference Venue
Online via Zoom
Conference in Webinar ICLCDD - 2024
In Associations With

Our Associates

Our Valuable associate.

Our Media Partners

Our Valuable media partners